Article |

Neuroleptic Withdrawal in Schizophrenic Patients

Gianni L. Faedda, MD; Ross J. Baldessarini, MD; Adele C. Viguera, MD; David L. Garver, MD; Trisha Suppes, MD, PhD; Leonardo Tondo, MD; Daniel van Kammen, MD, PhD; Richard J. Wyatt, MD; David M. Gardner
Arch Gen Psychiatry. 1995;52(3):189-192. doi:10.1001/archpsyc.1995.03950150021002.
Text Size: A A A
Published online

IN THIS issue of the Archives, Gilbert and her colleagues1 provide a scholarly, comprehensive meta-analysis of research concerning the discontinuation of neuroleptic treatment. We find that additional information can be obtained from their analyses, which adds to an emerging impression that abrupt withdrawal of neuroleptic drugs and other maintenance medications is associated with a high risk for early recurrence of acute illness. Their analysis involves a total of nearly 5600 psychotic patientsubjects in 66 studies reported between 1958 and 1993, including 29 paired comparisons with cohorts continued on treatment with medication. The results strongly indicate that the discontinuation of maintenance neuroleptic medication carries a significant early risk for severe exacerbation of illness ("relapse"), averaging 53% within 9.7 months after discontinuation vs 15.6% with continued medication. These results accord closely with a similar analysis of this literature up to the early 1980s, in which the risk after stopping neuroleptic treatment


Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview





Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.